TR200100352T2 - Nöro-koruyucu maddeler olarak yararlı yeni bileşikler - Google Patents

Nöro-koruyucu maddeler olarak yararlı yeni bileşikler

Info

Publication number
TR200100352T2
TR200100352T2 TR2001/00352T TR200100352T TR200100352T2 TR 200100352 T2 TR200100352 T2 TR 200100352T2 TR 2001/00352 T TR2001/00352 T TR 2001/00352T TR 200100352 T TR200100352 T TR 200100352T TR 200100352 T2 TR200100352 T2 TR 200100352T2
Authority
TR
Turkey
Prior art keywords
neuroprotective agents
compounds useful
new compounds
useful
neuroprotective
Prior art date
Application number
TR2001/00352T
Other languages
English (en)
Inventor
Alan Anderson Bejamin
Joseph Heinz Lawrence
Ann Panetta Jill
Leroy Phillips Michael
Allan Rieck John Iii
Robert Rizzo John
Kevin Shadle John
Lee Varie David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200100352T2 publication Critical patent/TR200100352T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bu bulus, nöro-koruycu maddeler olarak yararli olan yeni fenil oksazoller, tiazoller, oksazolinler, oksadiazoller ve benzoksazollere iliskindir.
TR2001/00352T 1997-10-06 1998-09-23 Nöro-koruyucu maddeler olarak yararlı yeni bileşikler TR200100352T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6101397P 1997-10-06 1997-10-06

Publications (1)

Publication Number Publication Date
TR200100352T2 true TR200100352T2 (tr) 2001-06-21

Family

ID=22033099

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/00352T TR200100352T2 (tr) 1997-10-06 1998-09-23 Nöro-koruyucu maddeler olarak yararlı yeni bileşikler
TR2000/01750T TR200001750T2 (tr) 1997-10-06 1998-09-23 Nöro-koruyucu maddeler olarak yararlı yeni bileşikler.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2000/01750T TR200001750T2 (tr) 1997-10-06 1998-09-23 Nöro-koruyucu maddeler olarak yararlı yeni bileşikler.

Country Status (16)

Country Link
US (1) US6448396B2 (tr)
EP (1) EP0908454A3 (tr)
JP (1) JP2001519341A (tr)
KR (1) KR20010024402A (tr)
CN (1) CN1281442A (tr)
AU (1) AU9575698A (tr)
BR (1) BR9812857A (tr)
CA (1) CA2305538A1 (tr)
EA (1) EA200000403A1 (tr)
HU (1) HUP0004862A3 (tr)
ID (1) ID24564A (tr)
IL (1) IL135433A0 (tr)
NO (1) NO20001751L (tr)
PL (1) PL339673A1 (tr)
TR (2) TR200100352T2 (tr)
WO (1) WO1999018091A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472387B1 (en) 1996-10-07 2002-10-29 Eli Lilly And Company Methods of using compounds as neuro-protective agents
HUP9904682A3 (en) * 1996-10-07 2001-09-28 Lilly Co Eli Phenyloxazole and -thiazole derivatives, their use and pharmaceutical compositions containing them
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
TWI248438B (en) * 2001-04-10 2006-02-01 Sod Conseils Rech Applic Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US7179808B2 (en) 2002-07-03 2007-02-20 Janssen Pharmaceutica N.V. Substituted heteroaryl and heterocyclic compounds useful in treating inflammatory disorders
KR101799429B1 (ko) * 2010-05-03 2017-11-21 에스케이바이오팜 주식회사 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
EP2628733B1 (en) * 2010-10-14 2014-12-24 Daiichi Sankyo Company, Limited Acylbenzene derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
DE3425118A1 (de) 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
DE3621775A1 (de) 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
EP0382199A1 (en) 1989-02-08 1990-08-16 Takeda Chemical Industries, Ltd. Oxazole compounds and their use
CA2073981C (en) 1990-11-30 2002-01-08 Shiro Kondo 2-arylthiazole derivatives and pharmaceutical composition thereof
US5633271A (en) 1992-05-26 1997-05-27 E. I. Du Pont De Nemours And Company Arthropodicidal oxazolines and thiazolines
DE4304197A1 (de) 1993-02-12 1994-08-18 Bayer Ag Substituierte Oxazole
US5428048A (en) 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
HUP9904682A3 (en) * 1996-10-07 2001-09-28 Lilly Co Eli Phenyloxazole and -thiazole derivatives, their use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2001519341A (ja) 2001-10-23
AU9575698A (en) 1999-04-27
BR9812857A (pt) 2000-08-08
KR20010024402A (ko) 2001-03-26
NO20001751D0 (no) 2000-04-05
HUP0004862A3 (en) 2001-12-28
US6448396B2 (en) 2002-09-10
EA200000403A1 (ru) 2000-10-30
TR200001750T2 (tr) 2001-01-22
HUP0004862A2 (hu) 2001-10-28
EP0908454A3 (en) 2001-07-25
CA2305538A1 (en) 1999-04-15
EP0908454A2 (en) 1999-04-14
US20010027194A1 (en) 2001-10-04
WO1999018091A1 (en) 1999-04-15
CN1281442A (zh) 2001-01-24
ID24564A (id) 2000-07-27
IL135433A0 (en) 2001-05-20
NO20001751L (no) 2000-05-03
PL339673A1 (en) 2001-01-02

Similar Documents

Publication Publication Date Title
TR199901559T2 (tr) Sinir hücrelerini koruyucu (nöro-protektif) maddeler olarak yararli yeni bilesikler.
TR199901653T2 (tr) Fitalazinonlar.
TR200401772T4 (tr) hPPAR alfa aktivatörleri olarak ikame edilmiş oksazol ve tiyazol türevleri.
ATE264313T1 (de) Substituierte oxazole und thiazole derivate als hppar-gamma und hppar-alpha aktivatore
TR199800679T2 (tr) Kiral metil fenil oksazolidinon.
ID17504A (id) Mesilat trihidrat 5-(2-(4-1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-kloro-1,3-dihidro-2h-indol-2-on
ATE293611T1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
TR200000340T2 (tr) Mananaz ve kil ihtiva eden deterjan bileşimleri.
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
DE69602970T2 (de) 5-(phenyl)-3-(4-piperidinyl)-1,3,4-oxadiazol-2(3h)-on-derivate verwendbar als 5-ht4- oder h3-rezeptorliganden
NO995846D0 (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
ATE258930T1 (de) Dihydrobenzifurane
TR200001554T2 (tr) Yeni bileşimler.
TR200100352T2 (tr) Nöro-koruyucu maddeler olarak yararlı yeni bileşikler
TR199903014T2 (tr) 5-HT1F Agonistleri olarak yararli karboksamitler.
DE60223805D1 (de) Oxazol/thiazol-derivate als aktivatoren des hppar-alpha-rezeptors
ATE197153T1 (de) Pyridiniminyl-1,2-benzisoxazole und- benzisothiazole als antipsychotika
ATE329913T1 (de) Oxazole als mglur1 verstärker
NO954892D0 (no) Heterosyklisk kjemi
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.
ES2172918T3 (es) Derivado de piperidinilmetiloxazolidinona.
BR9800601A (pt) Produção de derivados de oxazol
DE59905847D1 (de) Benzimidazole und oxazole
TR200102244T2 (tr) Kalsilitik bileşikler